by Maria Zannes | Mar 3, 2021 | Press Releases
MARCH 3, 2021 (SAN ANTONIO, TX) Peer-Reviewed Paper Explains How Porphyrins Used in Company’s Diagnostic and Therapeutic Platforms Enter Cancer Cells bioAffinity Technologies, a privately held company focused on early diagnostics and cancer therapeutics, announced...
by Dale Harrison | Feb 25, 2021 | Publications
“Identification of a novel mechanism for meso‐tetra (4‐carboxyphenyl) porphyrin (TCPP) uptake in cancer cells” Journal of the Federation of Societies for the Study of Experimental Biology (FASEB Journal), Feb. 25, 2021 Authors David J. Elzi, William E....
by Maria Zannes | Feb 16, 2021 | Events
Dr. David Elzi will present the poster “Meso-tetra (4-carboMeso-tetra (4-carboxyphenyl) porphyrin (TCPP) is taken up in cancer cells by the CD320 receptor” at the International Conference on Porphyrins and Phthalocyanines (ICPP) ICPP-11 virtual from June 26 through...
by Maria Zannes | Feb 11, 2021 | News
FEBRUARY 8, 2021 As published in the San Antonio Business Journal By: W. Scott Bailey – Senior Reporter, San-Antonio Business Journal “China represents a $5 billion market for CyPath© Lung. An estimated 780,000 people will be diagnosed annually in China with lung...
by Maria Zannes | Feb 5, 2021 | Events
Dr. David Elzi will present his poster “Simultaneous knockdown of CD320 and LRP2 receptors is selectively toxic to cancer cells but not normal cells” at the American Association of Cancer Research (AACR) Virtual Annual Meeting 2021, April 10-15 and May 17-21. Session:...
